Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Asthma and Allergy is Scopus-indexed (Q1, CiteScore 5.8), WoS SCIE, DOAJ. Published by Dove Medical Press Ltd.
Checked against the index lists dated .
ISSN 1178-6965Verify ISSN ↗
Publisher: Dove Medical Press Ltd
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 40 / 165 | 76th | Q1 |
| Immunology and Allergy | 93 / 234 | 60th | Q2 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2008–present, best quartile Q1, CiteScore 5.8.
Journal of Asthma and Allergy is Q1 in Pulmonary and Respiratory Medicine (rank 40 of 165) and Q2 in Immunology and Allergy (rank 93 of 234), by CiteScore 2025.
Journal of Asthma and Allergy is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 5.8, which places it in quartile Q1 at the 76th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.983, quartile Q1, with an H-index of 51.
The publisher lists an article processing charge of about US$2,836 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Asthma and Allergy is published by Dove Medical Press Ltd. Its ISSN is 1178-6965.
Yes — indexed in the Science Citation Index Expanded.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Asthma and Allergy has an h-index of 60 and a 2-year mean of 2.9 citations per paper (OpenAlex). Its Scopus CiteScore is 5.8, quartile Q1. On 2-year citations it ranks #33 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Journal of Asthma and Allergy published 148 papers in 2025; its busiest recent year was 2022 with 151. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (42.2%), United States (10.6%) and Japan (5%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.